Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112.
Companies Reporting Before The Bell
• Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Companies Reporting Before The Bell
• Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter.
• Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
Haemonetics Corporation (NYSE:HAE) reported fourth-quarter FY23 revenues of $304.42 million, beating the consensus of $289.64 million. Revenues rose 14.9% year…